Morgan Stanley’s LianBio American Depositary Shares LIAN Stock Holding History

Morgan Stanley’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,012	Closed	-$8.99K	–	8038
2023 Q4	$8.99K	Buy	2,012 +1,011	+101%	+$3.48K	﹤0.01%	6857
2023 Q3	$1.49K	Hold	1,001	–	–	﹤0.01%	7176
2023 Q2	$2.28K	Hold	1,001	–	–	﹤0.01%	7166
2023 Q1	$1.96K	Hold	1,001	–	–	﹤0.01%	7238
2022 Q4	$1.64K	Sell	1,001 -54,145	-98%	-$84.4K	﹤0.01%	7403
2022 Q3	$110K	Buy	55,146 +54,145	+5,409%	+$130K	﹤0.01%	6032
2022 Q2	$2K	Sell	1,001 -3,018	-75%	-$10.2K	﹤0.01%	7621
2022 Q1	$15K	Buy	+4,019	New	+$16.6K	﹤0.01%	7273

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Morgan Stanley's LIAN Position: Q1 2024 in Review

Morgan Stanley sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 2,012 shares — an estimated $8.99K sold.

Morgan Stanley first reported a position in LIAN in Q1 2022 and held it in 8 quarters. The position peaked at $110K in Q3 2022. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Morgan Stanley reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Morgan Stanley sold 2,012 LianBio American Depositary Shares shares in Q1 2024, an estimated $8.99K.
Morgan Stanley first reported a position in LianBio American Depositary Shares in Q1 2022 and held it in 8 quarters.
Morgan Stanley's LianBio American Depositary Shares position peaked at $110K in Q3 2022.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.